A vaccine for coeliac disease could soon be made available with the Australian-developed immunisation gaining fast-track designation from America’s Food and Drug Administration. ImmusanT’s Nexvax2, developed at the Walter and Eliza Hall Institute (WEHI) in Victoria, is set for a prompt review at the completion of its trial phases. Currently phase two, involving 150 patients…

Read More

People living with debilitating cases of motor neuron disease have been given revived hope following a “huge breakthrough” in treatment options by Australian researchers. A drug being hailed “ground breaking” was shown to slow the progression of the disease after being tested on 32 patients in Melbourne and Sydney. Professor Ashley Bush, chief scientific officer…

Read More